Biotech company Phylogica announced it had increased its shareholding in Vision Pharma to 90 per cent, following a $15 million investment using funds it had raised through a recent rights issue.
14/11/2019 - 15:38
Phylogica invests $15m into Vision Pharma
14/11/2019 - 15:38